Association of Monoamine Oxidase A Gene Promoter Region (30 bp μVNTR) Polymorphism with Serum Levels in Multiple Psychiatric Disorders

Association of Monoamine Oxidase A Gene Promoter Region (30 bp μVNTR) Polymorphism with Serum Levels in Multiple Psychiatric Disorders

<b>Background:</b> Monoamine oxidase A (MAOA) has a role in metabolising different biogenic amines, including dopamine. Functional studies have revealed the effect of promoter region variants on the transcriptional activity of the <i>MAOA</i> that consequently affects the hom...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aisha Nasir Hashmi, Rizwan Taj, Zehra Agha, Raheel Qamar, Jamal B. Williams, Maleeha Azam
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Biomedicines
Subjects:	monoamine oxidase functional polymorphisms psychiatric disorders population genetics
Online Access:	https://www.mdpi.com/2227-9059/13/3/698
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis of 1,2,4-Oxadiazin-5(6<i>H</i>)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors
by: Sofia I. Presnukhina, et al.
Published: (2024-11-01)

Molecular docking, drug-likeness properties, and toxicity prediction of alkaloidal phytoconstituents of piper longum against monoamine oxidase enzyme-A as an anti-depressive agent
by: Santosh Prasad Chaudhary kurmi, et al.
Published: (2025-05-01)

Autoantibody profiling of autism spectrum disorder patients with monoamine oxidase a deficiency
by: Guan-Da Syu, et al.
Published: (2025-08-01)

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease
by: Ayesha Asim, et al.
Published: (2025-07-01)

New class of thio/semicarbazide-based benzyloxy derivatives as selective class of monoamine oxidase-B inhibitors
by: Namitha Chandran, et al.
Published: (2024-12-01)

Improved approaches to genotyping MAOA-uVNTR polymorphisms with novel allele discovery
by: Areerat Hnoonual, et al.
Published: (2025-07-01)

In silico and in vivo evaluations of fisetin and fisetin-loaded nanosuspension on monoamine oxidase inhibition in Aβ(25–35) induced dementia in mice model
by: Siti Zaidathul Iman Zolkiffly, et al.
Published: (2024-12-01)

In Vitro Evaluation of Novel Furo[3,2-<i>c</i>]coumarins as Cholinesterases and Monoamine Oxidases Inhibitors
by: Mariagrazia Rullo, et al.
Published: (2025-04-01)

Resveratrol and Its Metabolite as Potential Allosteric Regulators of Monoamine Oxidase A Activity in the Brain and Liver Under Chronic Predator Stress
by: Jurica Novak, et al.
Published: (2025-05-01)

Meta-analysis examining the association between low platelet monoamine oxidase levels and Zuckerman's sensation seeking scale in a sex dependent manner
by: Jordan Winfield, et al.
Published: (2025-02-01)

Phthalocyanine-Modified Electrodes Used in the Electroanalysis of Monoamine Neurotransmitters
by: Anton Alexandru Ciucu, et al.
Published: (2025-07-01)

Ligand complex structures of l‐amino acid oxidase/monooxygenase from Pseudomonas sp. AIU 813 and its conformational change
by: Dohyun Im, et al.
Published: (2018-03-01)

Monoamine signaling and neuroinflammation: mechanistic connections and implications for neuropsychiatric disorders
by: Shalini Saggu, et al.
Published: (2025-04-01)

Khaya grandifololia exerts multitarget neuroprotective potential against neurodegenerative disorders: In vitro and in silico studies
by: Fils Armand Ella, et al.
Published: (2025-12-01)

Molecular Mechanisms of Rett Syndrome: Emphasizing the Roles of Monoamine, Immunity, and Mitochondrial Dysfunction
by: Julia Lopes Gonçalez, et al.
Published: (2024-12-01)

Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats
by: Vivian Fuguhara, et al.
Published: (2025-05-01)

Unraveling the Liver–Brain Axis: Resveratrol’s Modulation of Key Enzymes in Stress-Related Anxiety
by: Vadim E. Tseilikman, et al.
Published: (2024-09-01)

Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
by: Hongtao Du, et al.
Published: (2025-01-01)

Microwave-Assisted Synthesis of Morpholine-Based Chalcones as Reversible MAO-A Inhibitors in the Management of Mental Depression
by: Diksha Choudhary, et al.
Published: (2025-02-01)

Network Pharmacology and Metabolomics Reveal Anti-Ferroptotic Effects of Curcumin in Acute Kidney Injury
by: Liu X, et al.
Published: (2024-12-01)

Combined inhibition of dopamine D1/D2 receptors induces cognitive and emotional dysfunction through oxidative stress and dopaminergic neuron damage
by: Xue Li, et al.
Published: (2025-08-01)

Use of safinamide for treatment of Parkinson disease: real-world data from Spain
by: María Isabel Morales Casado, et al.
Published: (2025-07-01)

Severe isolated sulfide oxidase deficiency with a novel mutation
by: Meriç Ergene, et al.
Published: (2021-08-01)

Comparing the efficacy and safety of safinamide with rasagiline in China Parkinson’s disease patients with a matching adjusted indirect comparison
by: Yuyan Tan, et al.
Published: (2025-03-01)

Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01)

Differential susceptibility effects of the 5-HTTLPR and MAOA genotypes on decision making under risk in the Iowa gambling task
by: Mattias Rehn, et al.
Published: (2025-02-01)

Prenatal bisphenol A and/or diethylhexyl phthalate exposure followed by adult estradiol treatment affects behavior and brain monoamines in female rat offspring
by: Amrita Kaimal, et al.
Published: (2025-01-01)

Extraction conditions of polyphenol oxidase from banana peel
by: Baghdad Science Journal
Published: (2016-09-01)

Lysyl oxidase inhibitors in colorectal cancer progression
by: Muxian Liu, et al.
Published: (2025-02-01)

Characterization of a Pyranose Oxidase/<i>C</i>-Glycoside Oxidase from <i>Microbacterium</i> sp. 3H14, Belonging to the Unexplored Clade II of Actinobacterial POx/CGOx
by: Andrea Martschini, et al.
Published: (2024-11-01)

Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients
by: Chiara Bagnato, et al.
Published: (2025-03-01)

Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story
by: M. S. Eliseev, et al.
Published: (2023-08-01)

Determining the kinetic and optimum characteristics of glucose oxidase immobilized on polyurethane
by: Kalay Şaban
Published: (2024-08-01)

Xanthine oxidase inhibitors in asymptomatic hyperuricemia
by: O. V. Zhelyabina, et al.
Published: (2019-10-01)

The Role of Lysine Tyrosylquinone Containing Oxidases in Progression of Solid Tumors
by: Tatyana V. Korneenko, et al.
Published: (2025-06-01)

Lysyl Oxidase Mediates Proliferation and Differentiation in the Esophageal Epithelium
by: Kanak V. Kennedy, et al.
Published: (2024-12-01)

Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase
by: Claudia R. Oliva, et al.
Published: (2025-01-01)

Glucose oxidase: An emerging multidimensional treatment option for diabetic wound healing
by: Yuheng Liao, et al.
Published: (2025-02-01)

Octopamine alters yellow mealworm body composition
by: V. Hill, et al.
Published: (2025-05-01)

Inflammation Parameters, Xanthine Oxidase and Anti-Xanthine Oxidase Antibodies in Synovial Fluid of Patients Suffering from Arthritis
by: Nadjet Hanachi, et al.
Published: (2022-12-01)